1AI 0.00% 0.7¢ algorae pharmaceuticals limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 226 Posts.
    lightbulb Created with Sketch. 18
    I wonder how long this will take??????????? We are already 6 months behind since the cowboys from the west took over. Bernie had a plan and was meeting his targets. So frustrating.

    Delays in transportation of sensitive living choroid plexus tissue from Invercargill, New Zealand to Sydney, Australia has been identified as a challenge affecting the quality of NTCELL product manufactured in Australia. To address quality control issues associated with regulatory and shipping bottlenecks, LCT is exploring the engagement of a global Contract Research Organization (CRO) with infrastructure in New Zealand, to undertake manufacturing of NTCELL for the third clinical trial. NTCELL has previously been manufactured successfully in New Zealand where it was administered to clinical trial participants
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.